ArticlePharmaceutics2021

Augmented Therapeutic Potential of Glutaminase Inhibitor CB839 in Glioblastoma Stem Cells Using Gold Nanoparticle Delivery.

Beatriz Giesen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.